Beta-Lactam Resistance in Gram Negative Bacilli Flashcards

1
Q

Beta-Lactam Antibiotics: Mechanism of Action

A
• Penicillin binding  proteins (PBPs) are responsible for assembly, maintenance, and 
regulation of peptidoglycan 
(cell wall) metabolism
• Beta-lactams bind and 
inhibit PBPs
• Disruption of peptidoglycan synthesis
• Bactericidal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta-lactam antibiotics

A
• Penicillins
– Benzylpenicillin (natural)
– Ampicillin (extended spectrum)
– Piperacillin (Ureidopenicillin)
– Ticarcillin (Carboxypenicillin)
• Beta-lactam/beta-lactamase inhibitors
– Ampicillin/sulbactam (Unasyn)
– Amoxicillin/clavulanate (Augmentin)
– Ticarcillin/clavulanate (Timentin)
– Piperacillin/Tazobactam (Zosyn)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

B-lactam antibiotics : Cephalosporins

A
• First Generation cephalosporins
– Cefazolin
– Cephalothin
– Cefadroxil
• Second Generation oral antibiotics
– Cefuroxime (many others)
• Second Generation cephamycins
– Cefoxitin
– Cefotetan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta-lactam antibiotics : Cephalosporins continued

A
• Third generation cephalosporins
– Cefotaxime
– Ceftriaxone
– Ceftazidime
– Cefixime
• Fourth generation cephalosporins
– Cefepime
• Monobactams
– Aztreonam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Beta-lactam antibiotics : Carbapenems

A
• Carbapenems
– Imipenem
– Meropenem
– Ertapenem
– Doripenem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Resistance to Beta-Lactams

A

• Six “P’s” that can explain resistance to β-lactams:
– Penetration: poor access to intracellular bacteria
– Porins: prevent entry of β-lactams into bacterial cell
– Pumps: prevent accumulation of β-lactams in bacterial cell (efflux pumps)
– Penicillin-binding proteins: production of PBPs that do not bind β-lactams (or only bind certain types of beta-lactams)
– Peptidoglycan: some bacteria do not have a cell wall
– Penicillinases (β-lactamases): production of enzymes that hydrolyze β-lactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Location of β -lactamases

A

• Most β -lactamases of gram-negative species are periplasmic in location.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Classification of β-lactamases

A
• Four ways based on:
– Spectrum and preference of subsrates
– Susceptibility to inhibitors
– Chromosomal vs plasmid mediated
– Molecular Sequence
• Classification schemes include:
– Jack and Richmond (1970)
– Richmond and Sykes (1973)
– Ambler (1980 based on molecular phylogeny)
– Bush (1989, 1995) based on substrate preference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Molecular classification of β-lactamases

A

• Four molecular groupings: A,B,C, and D
– A,C, and D are all serine β-lactamases
– B is reserved for metallo β –lactamases (eg zinc requiring)
• There is good correlation between the Bush scheme and molecular taxonomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chromosomal β -lactamases:

Miscellaneous Gram-negative

A

• Pseudomonas aeruginosa
– Inducible, chromososmal Amp C
– Totally derepressed mutants occur at low frequency but can be selected by cephalosporin or ureido-penicillin therapy

• Stenotrophomonas maltophilia
– Produces 2 inducible, chromosomal enzymes both
regulated by the same induction system.
• One is a Class B metalloenzyme
• One is a Class A
– Between the two, the hit almost all β -lactams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Chromosomal β –lactamases–Klebsiella

A

• Primary Class A chromosomal enzymes
– K. pneumoniae = SHV-1
– K. oxytoca = KOXY
• All are constitutive but at levels to produce
resistance to ampicillin, amoxicillin, ticarcillin, etc

  • Regardless of MIC, no unprotected penicillin should be used against Klebsiella
  • Higher and broader levels of resistance in Klebsiella are usually caused by plasmid-mediated or hyperproduced B-lactamases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ESBL - Extended Spectrum Beta-Lactamase

A
• Class A, plasmid encoded enzymes
• Derivatives (mutants) of original TEM-1 and SHV-1 -lactamases
• Spreading throughout the Enterobacteriaceae
• More than 200 described to date
• Labile 
– 1st and 3rd generation cephalosporins
– Ureidopenicillins
• Stable 
– Cephamycins
– Carbapenems
– Cefepime**
• Inhibited by Beta-lactamase inhibitors
– Tazobactam
– Sulbactam
– Clavulanate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Extended Spectrum β-Lactamases

A

● Extended Spectrum β-Lactamases (ESBLs) are Ambler class A enzymes.
● Encoded on either the chromosome or mobile genetic elements.
● Inhibited by β-lactamase inhibitors e.g., clavulanic acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AmpC β-lactamases

A

• Can be encoded on chromosome (SPACE
organisms)
– Serratia, Providencia/Proteus
vulgaris/Pseudomonas, Acinetobacter,
Citrobacter freundii complex, Enterobacter
• Constitutive expression
• Penicillins, First- and Second- generation cephalosporins are hydrolyzed (and usually 3rd
-gen but R to 3rd gen not always detected in vitro)
• In Enterobacteriaceae, expression can be “upregulated” by exposure to beta-lactam antibiotics (esp carbapenems) and beta-lactamse inhibitors

• Cefepime and carbapenems are not hydrolyzed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AmpC β-lactamases

Continued

A

• Plasmid mediated AmpC
– Kleb, E. coli
– Clue=cefoxtin resistance in these organisms
• ESBL “skips” a generation—cephamycins are not
hydrolyzed, first and third generation cephalosporins
are usually resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AmpCs

A

● AmpCs are Ambler class C enzymes.
● Encoded on the chromosome (SPACE organisms) or mobile genetic elements.
● Expression of chromosomal-encoded enzymes can be induced.
● Inhibited by cloxacillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ESBL vs. AmpC

A

• Plasmid (ESBL) vs. Chromosomal (AmpC)
• Inhibited by β-lactamase inhibitors (ESBL) vs. not
inhibited (AmpC)
• Cephamycin S (ESBL) vs. Cephamycin R (AmpC)
• Sometimes confers Cefepime R (ESBL) vs. does not confer Cefepime R (AmpC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CRE

A

– Carbapenem Resistant Enterobacteriaceae
• Generic descriptor until mechanism of resistance has been established
– Exception: Proteus and Proteus-like (Proteus,
Morganella, Providencia) intrinsically have reduced susceptibility to Imipenem

19
Q

CRE—CDC Definition

A

• Enterobacteriaceae that are non-susceptible to one of: doripenem, meropenem or
imipenem
AND
• Resistant to all of the third generation cephalosporins tested (ceftriaxone, cefotaxime, and ceftazidime)

20
Q

CRE

A
• May be attributed to:
– Acquisition of a Carbapenemase enzyme 
 (eg. KPC, IMP, VIM, NDM-1, OXA-48)
OR
– ESBL and/or AmpC with a porin or efflux mutation
21
Q

KPC

A

• Klebsiella pneumoniae Carbapenemase
• Molecular class A
– In vitro, inhibited by clavulanic acid but not by EDTA
• Confers resistance to ALL -LACTAM antibiotics in vivo
• Plasmid-encoded
– Transferable
– Can be found in all Enterobacteriaceae
– Typically other resistance genes transmitted on the same plasmid (aminoglycosides,
fluoroquinolones)

22
Q

Klebsiella pneumoniae Carbapenemases

A
● Klebsiella pneumoniae (Kpne) carbapenemases (KPC) are Ambler class A enzymes
•Can be found in all Enterobacteriaceae
23
Q

KPC at Barnes

A

• First “arrived” at BJH in 2007
– Index patient: surgery in South America
• Approximately 150 unique patients with KPC positive isolates to date
• 2011/2012: Average 2 new patients/month
• Many of the isolates are susceptible to Gent (but
resistant to Tobra and Amikacin)
• Most isolates susceptible to colistin and tigecycline (and sometimes that is all)
• About ¼ of the isolates test susceptible to cefepime in vitro (but reported as R)

24
Q

KPC at Barnes - continued

A

• Mostly isolated from urine and tracheal aspirate samples
• ~1% of Enterobacteriaceae
• Most patients have been in long term care facilities prior to transfer to BJH
• Small number of isolates from blood cultures, and one from CSF
• Many different species
– K. pneumoniae, K. oxytoca, E. coli, Serratia, Proteus, E.
cloacae, E. aerogenes, Citrobacter freundii complex

25
Q

NDM-1 Beta-Lactamase

A

• New Dehli Metallo-beta-lactamase-1
• Metallo beta-lactamase: requires zinc for enzyme
function
– Similar to other metallos (IMP and VIM)
• Plasmid encoded
• Now seen world-wide
• Becoming widespread in Europe and Asia
• In the UK:
– Now the predominant mechanism of carbapenem
resistance
– Spread not clonal

26
Q

NDM-1 Beta-Lactamase : Continued

A

• Although molecular class B, most isolates aztreonam resistant
• Typically resistant to other classes of antimicrobials
• Origin unknown (environmental source?)
• Reported in all Enterobacteriaceae, although E.
coli and Klebsiella spp. most common
• Most patients have an epi-link to India
• Many specimen types
• Both community and hospital-associated cases

27
Q

Metallo-β-Lactamases

A

● Metallo--Lactamases (MBL) are Ambler class B enzymes (active site Zn2+ enzyme).
● Encoded on the chromosome or mobile genetic elements.
NDM-1: mobile genetic element, rare chromosomal insertions reported
● Inhibited by metal-chelating agents: e.g., dipicolinic acid and EDTA.

28
Q

OXA-48

A

• OXA
– “Oxacillinase”
– Class D beta-lactamase
• Much variability of spectrum of Class D
• Not inhibited by beta-lactamase inhibitors
• Do not require divalent cations
• Can be chromosomal or on mobile genetic elements

29
Q

OXA-48 - Continued

A

• Until recently, associated with Acinetobacter but not Enterobacteriaceae
• Until recently, not reported in US
– Middle East, North Africa, India, Europe
• 2013: First reports of OXA-48 in USA
– Klebsiella pneumoniae; patients with epi-links to
India and Saudi Arabia

30
Q

Automated Susceptibility Testing Methods

A

• Vitek2
– Card with ability to test 19-25 agents (and might infer more based on expert rules)
• Growth curves are used to
determine MIC
• BD Phoenix
– 84 well system with approx. 20 antimicrobial agents
– Reading every 20 min with colorimetric growth detection (redox indicator in wells)
• Microscan
– Microbroth dilution method

31
Q

Automated Systems and KPC…

A

• AST systems are IVDs regulated by FDA, can’t
change interpretive criteria until FDA does
• Most don’t currently have low enough dilutions to accommodate new breakpoints
• Labs that rely exclusively on automated systems for CRE detection are likely underreporting these organisms

32
Q

BJH Laboratory Workflow

A
• No Modified Hodge!!!
• Alert to isolates with 
reduced meropenem 
susceptibility
– Lab developed KPC PCR 
assay
• TaqMan
• Smart Cycler
– MDR panel set up
33
Q
Case
• Specimen: Blood
• Organism: Klebsiella pneumoniae
• Susceptibility profile:
– Ampicillin: S
– Cefazolin: S
– Cefotetan: S
– Ceftriaxone: S
– Ceftazidime: S
– Cefepime: S
– Meropenem: S
– Trimethoprim-Sulfamethoxazole: S
A

answer here

34
Q

Case

A
• Specimen: Blood
• Organism: Klebsiella pneumoniae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: S
– Cefotetan: S
– Ceftriaxone: S
– Ceftazidime: S
– Cefepime: S
– Meropenem: S
– Trimethoprim-Sulfamethoxazole: S
35
Q

Case

• Specimen: Blood
• Organism: Klebsiella pneumoniae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: S
– Ceftriaxone: R
– Ceftazidime: S
– Cefepime: R
– Meropenem: S
– Trimethoprim-Sulfamethoxazole: S
A

answer here

36
Q
Case 
• Specimen: Blood
• Organism: Klebsiella pneumoniae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: S
– Cefepime: S
– Meropenem: S
– Trimethoprim-Sulfamethoxazole: S
A

answer here

37
Q
Case
• Specimen: Blood
• Organism: Klebsiella pneumoniae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: R
– Meropenem: R
– Trimethoprim-Sulfamethoxazole: S
A

answer here

38
Q
Case
• Specimen: Urine
• Organism: Enterobacter cloacae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: S
– Meropenem: S
– Trimethoprim-Sulfamethoxazole: S
A

answer here

39
Q
Case 
• Specimen: Urine
• Organism: Enterobacter cloacae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: R
– Meropenem: R
– Trimethoprim-Sulfamethoxazole: S
A

answer here

40
Q
Case
• Specimen: Urine
• Organism: Enterobacter cloacae
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: S
– Meropenem: R
– Trimethoprim-Sulfamethoxazole: S
A

Answer here

41
Q
Case
• Specimen: Tracheal Aspirate
• Organism: Stenotrophomonas maltophilia
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: S
– Meropenem: S
– Trimethoprim-Sulfamethoxazole: S
A

answer here

42
Q
Case
• Specimen: Tracheal Aspirate
• Organism: Stenotrophomonas maltophilia
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: R
– Meropenem: R
– Trimethoprim-Sulfamethoxazole: S
A

answer here

43
Q
Case
• Specimen: Tracheal Aspirate
• Organism: Stenotrophomonas maltophilia
• Susceptibility profile:
– Ampicillin: R
– Cefazolin: R
– Cefotetan: R
– Ceftriaxone: R
– Ceftazidime: R
– Cefepime: R
– Meropenem: R
– Trimethoprim-Sulfamethoxazole: R
A

answer here